KTRA — Kintara Therapeutics Balance Sheet
0.000.00%
- $13.94m
- $17.84m
Annual balance sheet for Kintara Therapeutics, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 3.72 | 2.39 | 10.5 | 11.8 | 1.53 |
Net Total Receivables | 0.026 | 0.009 | — | — | — |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 4.03 | 2.85 | 11.8 | 13.3 | 3.27 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | — | 0.15 | 0.09 | 0.709 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 4.04 | 2.94 | 13.5 | 15.9 | 3.98 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.07 | 2.67 | 2.78 | 3.99 | 3.08 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.07 | 2.67 | 2.96 | 4.15 | 3.25 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 1.97 | 0.263 | 10.6 | 11.8 | 0.731 |
Total Liabilities & Shareholders' Equity | 4.04 | 2.94 | 13.5 | 15.9 | 3.98 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |